A Novel Cold and Flu Herbal Blend for Reducing the Duration and Severity of the Common Cold

The aim of this study is to evaluate the efficacy of a Novel Herbal Cold \& Flu Blend in reducing the duration of symptoms of the common cold. The secondary objective is to assess whether the investigational product reduces the severity of symptoms. Participants will be enrolled for 16 weeks, during this period they will take the assigned study product when they experience URTI symptoms.

NCT Number	NCT07642648
Lead Sponsor	RDC Clinical Pty Ltd Collaborators: iNova Pharmaceuticals
Conditions	URTI, Common Cold
Enrollment	300 participants
Start Date	2026-07
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2026-06-11